PharmChain: A data-driven scenario-based drug traceability and regulation blockchain framework

Amrendra Singh Yadav , Vincent Charles , Tatiana Gherman , Vinay Kumar , Vijayant Pawar , Nishchay Chaudhary
{"title":"PharmChain: A data-driven scenario-based drug traceability and regulation blockchain framework","authors":"Amrendra Singh Yadav ,&nbsp;Vincent Charles ,&nbsp;Tatiana Gherman ,&nbsp;Vinay Kumar ,&nbsp;Vijayant Pawar ,&nbsp;Nishchay Chaudhary","doi":"10.1016/j.dajour.2025.100620","DOIUrl":null,"url":null,"abstract":"<div><div>The manufacturing and distribution of counterfeit tablets, especially in developing countries, is an urgent and increasingly critical global problem. Falsified medicinal products may contain incorrect ingredients and doses. One of the reasons for drug counterfeiting is the imperfect supply chain system in the pharmaceutical industry. Medicinal products are moved between manufacturers, suppliers, wholesalers, retailers, and pharmaceutical firms before meeting consumers. This study proposes PharmChain, a scenario-oriented drug traceability and regulation blockchain framework that reconstructs the entire service infrastructure by splitting the service provider into three separate service components and ensuring the authenticity and privacy of traceability details. PharmChain can track medication development via patient supply in the pharmaceutical industry. An Ethereum-based blockchain stores the transactions, and only trusted parties can access the data through the chain. We create and test our smart contract code in the Remix environment. We present detailed cost and security analyses incurred by supply chain stakeholders. We also use cost analysis to assess the performance of the proposed solution and demonstrate its affordability.</div></div>","PeriodicalId":100357,"journal":{"name":"Decision Analytics Journal","volume":"17 ","pages":"Article 100620"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Decision Analytics Journal","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772662225000761","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The manufacturing and distribution of counterfeit tablets, especially in developing countries, is an urgent and increasingly critical global problem. Falsified medicinal products may contain incorrect ingredients and doses. One of the reasons for drug counterfeiting is the imperfect supply chain system in the pharmaceutical industry. Medicinal products are moved between manufacturers, suppliers, wholesalers, retailers, and pharmaceutical firms before meeting consumers. This study proposes PharmChain, a scenario-oriented drug traceability and regulation blockchain framework that reconstructs the entire service infrastructure by splitting the service provider into three separate service components and ensuring the authenticity and privacy of traceability details. PharmChain can track medication development via patient supply in the pharmaceutical industry. An Ethereum-based blockchain stores the transactions, and only trusted parties can access the data through the chain. We create and test our smart contract code in the Remix environment. We present detailed cost and security analyses incurred by supply chain stakeholders. We also use cost analysis to assess the performance of the proposed solution and demonstrate its affordability.
PharmChain:基于数据驱动的基于场景的药品可追溯性和监管区块链框架
假冒片剂的生产和分销,特别是在发展中国家,是一个紧迫和日益严重的全球性问题。伪造的药品可能含有不正确的成分和剂量。制药业供应链体系不完善是制药业假冒药品的原因之一。药品在与消费者见面之前要在制造商、供应商、批发商、零售商和制药公司之间流动。本研究提出了面向场景的药品追溯与监管框架PharmChain,该框架通过将服务提供商拆分为三个独立的服务组件,并确保追溯细节的真实性和私密性,重构了整个服务基础设施。PharmChain可以通过制药行业的患者供应来跟踪药物开发。基于以太坊的区块链存储交易,只有受信任的方才能通过链访问数据。我们在Remix环境中创建和测试智能合约代码。我们提供了供应链利益相关者产生的详细成本和安全分析。我们还使用成本分析来评估所建议的解决方案的性能,并证明其可负担性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.90
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信